Predictors of the outcome of immune tolerance induction in patients with haemophilia A and inhibitors: The Brazilian Immune Tolerance (BrazIT) Study protocol

The development of inhibitors is the main complication of haemophilia A (HA) treatment. Immune tolerance induction (ITI) is the treatment of choice for inhibitor eradication. We describe the methodology of the Brazilian Immune Tolerance Induction (BrazIT) Study, aimed to identify clinical, genetic,...

Descripción completa

Detalles Bibliográficos
Autores principales: Camelo, Ricardo Mesquita, Chaves, Daniel Gonçalves, Zuccherato, Luciana Werneck, Rezende, Suely Meireles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389515/
https://www.ncbi.nlm.nih.gov/pubmed/34437573
http://dx.doi.org/10.1371/journal.pone.0256265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8389515/
https://www.ncbi.nlm.nih.gov/pubmed/34437573
http://dx.doi.org/10.1371/journal.pone.0256265

Ejemplares similares